84 related articles for article (PubMed ID: 8713103)
1. Differential effects of progestins and estrogens on long control regions of human papillomavirus types 16 and 18.
Chen YH; Huang LH; Chen TM
Biochem Biophys Res Commun; 1996 Jul; 224(3):651-9. PubMed ID: 8713103
[TBL] [Abstract][Full Text] [Related]
2. [Possible role of transcription factor AP1 in the tissue-specific regulation of human papillomavirus].
Velazquez Torres A; Gariglio Vidal P
Rev Invest Clin; 2002; 54(3):231-42. PubMed ID: 12183893
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional activation of the human papillomavirus type 5 and 16 long control region in cells from cutaneous and mucosal origin.
Mistry N; Simonsson M; Evander M
Virol J; 2007 Mar; 4():27. PubMed ID: 17352804
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of hormone response of human papillomavirus type 16 expression and increased DNA-protein binding by consensus mutations of viral glucocorticoid response elements.
Khare S; Kumar KU; Tang SC; Pater MM; Pater A
J Med Virol; 1996 Nov; 50(3):254-62. PubMed ID: 8923291
[TBL] [Abstract][Full Text] [Related]
5. Functional implication of sequence variation in the long control region and E2 gene among human papillomavirus type 18 variants.
López-Saavedra A; González-Maya L; Ponce-de-León S; García-Carrancá A; Mohar A; Lizano M
Arch Virol; 2009; 154(5):747-54. PubMed ID: 19337781
[TBL] [Abstract][Full Text] [Related]
6. Different arrangement of human papillomavirus E2 binding sites distinguishes cutaneous types from those associated with mucosal lesions.
Garrido-Guerrero E; Carrillo E; Guido M; Zamorano R; García-Carranca A; Gariglio P
Arch Med Res; 1996; 27(3):389-94. PubMed ID: 8854400
[TBL] [Abstract][Full Text] [Related]
7. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.
Vinokurova S; Wentzensen N; Kraus I; Klaes R; Driesch C; Melsheimer P; Kisseljov F; Dürst M; Schneider A; von Knebel Doeberitz M
Cancer Res; 2008 Jan; 68(1):307-13. PubMed ID: 18172324
[TBL] [Abstract][Full Text] [Related]
8. Altered growth and viral gene expression in human papillomavirus type 16-containing cancer cell lines treated with progesterone.
Yuan F; Auborn K; James C
Cancer Invest; 1999; 17(1):19-29. PubMed ID: 10999045
[TBL] [Abstract][Full Text] [Related]
9. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
[TBL] [Abstract][Full Text] [Related]
10. Effect of glucocorticoid hormones on viral gene expression, growth, and dysplastic differentiation in HPV16-immortalized ectocervical cells.
Khare S; Pater MM; Tang SC; Pater A
Exp Cell Res; 1997 May; 232(2):353-60. PubMed ID: 9168812
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta1 and IL-4 downregulate human papillomavirus-16 oncogene expression but have differential effects on the malignant phenotype of cervical carcinoma cells.
Donalisio M; Cornaglia M; Landolfo S; Lembo D
Virus Res; 2008 Mar; 132(1-2):253-6. PubMed ID: 18206261
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the long control region of human papillomavirus DNA in oral cancer cells, and their functional consequences.
Chen Z; Storthz KA; Shillitoe EJ
Cancer Res; 1997 Apr; 57(8):1614-9. PubMed ID: 9108468
[TBL] [Abstract][Full Text] [Related]
13. Physical status and expression of HPV genes in cervical cancers.
Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE
Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma.
Thierry F
Virology; 2009 Feb; 384(2):375-9. PubMed ID: 19064276
[TBL] [Abstract][Full Text] [Related]
15. HPV-2 isolates from patients with huge verrucae vulgaris possess stronger promoter activities.
Lei YJ; Wang C; Gao C; Jiang HY; Chen JM; Han J; Yuan YK; Dong XP
Intervirology; 2007; 50(5):353-60. PubMed ID: 17728546
[TBL] [Abstract][Full Text] [Related]
16. [Cloning of human papillomavirus type 16 E7 gene and expression in E. coli].
Liu C; Si J; Liu S; Xu X; Song G
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Jun; 20(3):168-72. PubMed ID: 11367700
[TBL] [Abstract][Full Text] [Related]
17. Effects of cytokines on long control region transcriptional activity in high-risk cutaneous human papillomavirus types 5 and 8.
Donalisio M; Poli A; Civra A; Landolfo S; Lembo D
Arch Virol; 2010 Apr; 155(4):583-7. PubMed ID: 20182754
[TBL] [Abstract][Full Text] [Related]
18. Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions.
Wentzensen N; Ridder R; Klaes R; Vinokurova S; Schaefer U; Doeberitz Mv
Oncogene; 2002 Jan; 21(3):419-26. PubMed ID: 11821954
[TBL] [Abstract][Full Text] [Related]
19. Retrovirus-mediated delivery of HPV16 E7 antisense RNA inhibited tumorigenicity of CaSki cells.
Choo CK; Ling MT; Suen CK; Chan KW; Kwong YL
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):293-301. PubMed ID: 10985883
[TBL] [Abstract][Full Text] [Related]
20. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
